API Category: Anti-cancer

Ruxolitinib is part of our Anti-cancer portfolio.

CAS Number: 941678-49-5

Paclitaxel is part of our Anti-cancer portfolio.

CAS Number: 33069-62-4

Fulvestrant is part of our Anti-cancer portfolio.

CAS Number: 129453-61-8